Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP

Recruiting now · Phase 2/Phase 3

Conditions studied: Pancreatic Adenocarcinoma

In brief

The effect of neoadjuvant chemotherapy for pancreatic cancer was gradually established. However it has been not clarified which regimen of neoadjuvant treatment for pancreatic cancer is the best.

Key facts

Study ID

NCT05268692

Run by

Kochi University

People needed

500

Starts

2019-01-01

Expected to finish

2030-12-31

Last updated by the study team

2022-03-07

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• elective pancreatectomy for pancreatic cancer

You may not qualify if…

• a previous cancer surgery a body weight loss of >10% during the 6 months before surgery the presence of distant metastases seriously impaired function of vital organs because of respiratory, renal, or heart disease.

Where it is running

• Takehiro Okabayashi — Kochi, Japan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.